![]() |
||||||
PI Perspective #48March 2009 View PDF En español A person's modifiable risk factors nearly double their risk of non-AIDS death
Data from the D:A:D study showed that factors which people can change and influence nearly double the risk of non-AIDS death. These medical and lifestyle issues include smoking, high blood pressure and diabetes. The D:A:D (Data collection on Adverse events of anti-HIV Drugs) is a large observational study examining the safety of HIV drugs and health outcomes of those on therapy. Just over 33,000 people were enrolled. Average age was 39, most were men (74%), 45% were white, more than half were either current smokers or had smoked, 34% had HBV or HCV disease, and 3% had diabetes. At the start of the study, about 3 out of 4 were taking therapy. Average CD4 count was 408 and average viral load was 1,000. The length of time on HIV therapy averaged just over 3 years. People were evaluated from the time they entered the study until their last follow-up visit (or death) through October 2007. Body mass index (low weight), blood pressure, diabetes, smoking, use of therapy, and current CD4 counts and viral loads were studied. A total of 2,192 deaths occurred during the period studied. Underlying causes of death included AIDS (32%), liver disease (14%), non-AIDS cancers (12%), heart disease (11%), bacterial infections (9%), non-natural deaths (9%), and other causes (13%.) The results showed the following:
Many of these, if not all, are not radically unknown risks for death in the general population let alone people living with HIV. However, the degree to which these factors increase the risk of death in HIV-positive people is striking. Given that people, with or without HIV, can make constructive changes to impact some of the issues that increase risk of death, it's important for people to take a proactive role in addressing what they can to prolong and improve their quality of life. Changes that people may do to reduce risks include:
|
CONTENTSKaletra & Isentress suppress HIV, have different side effects Two newcomers challenge ritonavir Risk factors double risk of non-AIDS death |
|||||
|
© 2009 Project Inform 1375
Mission Street, San Francisco, CA 94103 415-558-8669 |
||||||